1. Home
  2. Analysis
  3. Telmisartan
  4. Levofloxacin

Telmisartan and Levofloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 19 people who take Telmisartan and Levofloxacin. Common interactions include sudden death among females, and adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people who take Telmisartan and Levofloxacin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

19 people who take Telmisartan and Levofloxacin together, and have interactions are studied.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is used in high blood pressure. Currently, eHealthMe is studying from 7,150 Telmisartan users.

What is Levofloxacin?

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is used in sinusitis. Currently, eHealthMe is studying from 16,314 Levofloxacin users.

Number of Telmisartan and Levofloxacin reports submitted per year:

Telmisartan and Levofloxacin drug interactions.

Common Telmisartan and Levofloxacin drug interactions by gender *:

female:

  1. Sudden death
  2. Cytomegalovirus viraemia
  3. Febrile neutropenia
  4. Sepsis
  5. Acute generalised exanthematous pustulosis
  6. Basal cell carcinoma
  7. Dementia
  8. Erythema multiforme
  9. Face oedema
  10. Generalised oedema

male:

  1. Adrenal insufficiency
  2. Blindness
  3. Lung adenocarcinoma stage iii
  4. Lung infection
  5. Microcytosis
  6. Neoplasm malignant
  7. Neoplasm progression
  8. Pharyngitis
  9. Renal impairment
  10. Rhinitis

Common Telmisartan and Levofloxacin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Sudden death
  2. Blindness
  3. Conjunctival hyperaemia
  4. Corneal oedema
  5. Endophthalmitis
  6. Eye irritation
  7. Eye pain
  8. Vision blurred
  9. Myocardial infarction
  10. Pleural effusion

50-59:

n/a

60+:

  1. Adrenal insufficiency
  2. Cytomegalovirus viraemia
  3. Generalised oedema
  4. Hypoalbuminaemia
  5. Hypoglycaemia
  6. Liver disorder
  7. Lung adenocarcinoma stage iii
  8. Malaise
  9. Otitis media
  10. Postoperative wound complication

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 26.32%
  2. Aplastic Anemia: 4 people, 21.05%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 15.79%
  5. Pharyngitis (inflammation of the pharynx, causing a sore throat): 2 people, 10.53%
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 10.53%
  7. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 10.53%
  8. Fever: 2 people, 10.53%
  9. Fatigue (feeling of tiredness): 1 person, 5.26%
  10. Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Telmisartan and Levofloxacin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Telmisartan drug interactions:

Browse interactions between Telmisartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levofloxacin drug interactions:

Browse interactions between Levofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and levofloxacin; sodium chloride (the active ingredients of Telmisartan and Levofloxacin, respectively), and Telmisartan and Levofloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Telmisartan and Levofloxacin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.